TUDCA
Selected indexed studies
- Insights by which TUDCA is a potential therapy against adiposity. (Front Endocrinol (Lausanne), 2023) [PMID:36896173]
- TUDCA receptors and their role on pancreatic beta cells. (Prog Biophys Mol Biol, 2021) [PMID:34547326]
- Neuroprotective Effect of Tauroursodeoxycholic Acid (TUDCA) on In Vitro and In Vivo Models of Retinal Disorders: A Systematic Review. (Curr Neuropharmacol, 2024) [PMID:37691227]
_Worker-drafted node — pending editorial review._
Connections
TUDCA helps
TUDCA protects against
Sources
- Insights by which TUDCA is a potential therapy against adiposity. (2023) pubmed
- TUDCA receptors and their role on pancreatic beta cells. (2021) pubmed
- Neuroprotective Effect of Tauroursodeoxycholic Acid (TUDCA) on In Vitro and In Vivo Models of Retinal Disorders: A Systematic Review. (2024) pubmed
- The bile acid TUDCA and neurodegenerative disorders: An overview. (2021) pubmed
- Synthesis of TUDCA from chicken bile: immobilized dual-enzymatic system for producing artificial bear bile substitute. (2024) pubmed
- SEPN1-related myopathy depends on the oxidoreductase ERO1A and is druggable with the chemical chaperone TUDCA. (2024) pubmed
- Tauroursodeoxycholic acid: a potential therapeutic tool in neurodegenerative diseases. (2022) pubmed
- Long-term benefits of TUDCA supplement in ARSACS zebrafish model. (2025) pubmed
- TUDCA inhibits HSV-1 replication by the modulating unfolded protein response pathway. (2020) pubmed
- TUDCA inhibits EV71 replication by regulating ER stress signaling pathway and suppressing autophagy. (2024) pubmed